From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy
Current gene therapy, 2003 - ingentaconnect.com
Gene transfer vectors based on the human adeno-associated virus serotype 2 (AAV-2) have
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
[PDF][PDF] From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy
D Grimm, MA Kay - Current Gene Therapy, 2003 - academia.edu
Gene transfer vectors based on the human adeno-associated virus serotype 2 (AAV-2) have
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
[PDF][PDF] From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy
D Grimm, MA Kay - Current Gene Therapy, 2003 - researchgate.net
Gene transfer vectors based on the human adeno-associated virus serotype 2 (AAV-2) have
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy.
D Grimm, MA Kay - Current Gene Therapy, 2003 - europepmc.org
Gene transfer vectors based on the human adeno-associated virus serotype 2 (AAV-2) have
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
From virus evolution to vector revolution: use of naturally occurring serotypes of adeno-associated virus (AAV) as novel vectors for human gene therapy
D Grimm, MA Kay - Current gene therapy, 2003 - pubmed.ncbi.nlm.nih.gov
Gene transfer vectors based on the human adeno-associated virus serotype 2 (AAV-2) have
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
[PDF][PDF] From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy
D Grimm, MA Kay - Current Gene Therapy, 2003 - wayback.stanford.edu
Gene transfer vectors based on the human adeno-associated virus serotype 2 (AAV-2) have
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
[引用][C] From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy
D Grimm, M Kay - Current Gene Therapy, 2003 - cir.nii.ac.jp
From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated
Virus (AAV) as Novel Vectors for Human Gene Therapy | CiNii Research CiNii 国立情報学 …
Virus (AAV) as Novel Vectors for Human Gene Therapy | CiNii Research CiNii 国立情報学 …
[PDF][PDF] From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy
D Grimm, MA Kay - Current Gene Therapy, 2003 - Citeseer
Gene transfer vectors based on the human adeno-associated virus serotype 2 (AAV-2) have
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
[PDF][PDF] From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy
D Grimm, MA Kay - Current Gene Therapy, 2003 - med.stanford.edu
Gene transfer vectors based on the human adeno-associated virus serotype 2 (AAV-2) have
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
[PDF][PDF] From Virus Evolution to Vector Revolution: Use of Naturally Occurring Serotypes of Adeno-associated Virus (AAV) as Novel Vectors for Human Gene Therapy
D Grimm, MA Kay - Current Gene Therapy, 2003 - Citeseer
Gene transfer vectors based on the human adeno-associated virus serotype 2 (AAV-2) have
been developed and tested in pre-clinical studies for almost 20 years, and are currently …
been developed and tested in pre-clinical studies for almost 20 years, and are currently …